Matching placebo tablet, JNJ-67953964
67953964MDD3007
Phase 3 small_molecule active
Quick answer
Matching placebo tablet, JNJ-67953964 for Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active